Daptomycin Dosing for 85kg Female on Intermittent Hemodialysis Starting Friday
Give 510 mg (6 mg/kg × 85 kg) of daptomycin today (Friday), then administer the same dose post-dialysis on Sunday, Tuesday, and Thursday going forward.
Dosing Rationale
The FDA label explicitly states that for adults with CrCl <30 mL/min on hemodialysis, daptomycin should be dosed at 6 mg/kg every 48 hours when possible following completion of hemodialysis 1. However, this creates a practical problem with thrice-weekly dialysis schedules (Sunday/Tuesday/Thursday) because the 48-hour interval doesn't align with the asymmetric dialysis schedule, which includes two ~48-hour periods and one ~72-hour interdialytic period.
The Friday Start Problem
Since your patient dialyzes on Sunday, Tuesday, and Thursday, starting on Friday means:
- Friday to Sunday = 2 days (48 hours) - this aligns with standard dosing
- You can give the first dose today and it will be appropriately timed before her Sunday dialysis
Ongoing Thrice-Weekly Dosing Strategy
For bacteremia/endocarditis indications (6 mg/kg):
- Standard dose: 510 mg post-dialysis on Sunday and Tuesday
- Increased dose before 72-hour gap: 765 mg (1.5× the standard dose = 9 mg/kg) post-dialysis on Thursday
This dosing adjustment is supported by multiple pharmacokinetic studies demonstrating that the 72-hour interdialytic period (Thursday to Sunday) results in subtherapeutic drug levels without dose augmentation 2, 3, 4. The research consistently shows that an additional 50% of the dose should be provided before the 72-hour interdialytic period to maintain adequate serum concentrations 2, 3.
Key Evidence Supporting This Approach
The pharmacokinetic analysis by Kielstein et al. demonstrated that daptomycin has a half-life of approximately 19.4 hours off hemodialysis and is removed by approximately 50-58% during a 4-hour dialysis session 4. Monte Carlo simulations confirmed that increasing the parent dose by 50% before the 72-hour period maintains comparable AUC values while keeping trough concentrations below the safety threshold of 24.3 mg/L 3.
A 2014 analysis specifically addressing bacteremia patients with severe renal impairment confirmed that 6 mg/kg every 48 hours provides appropriate exposure for bacteremia indications, whereas 4 mg/kg would result in substantial underexposure 5.
Clinical Monitoring
- Monitor CPK levels at baseline and weekly, as one pharmacokinetic study showed higher probabilities of trough concentrations ≥24.3 mg/L in some hemodialysis patients, warranting more intensive CPK monitoring 3
- Ensure daptomycin is administered post-dialysis to avoid immediate removal by dialysis 1
- If administering during dialysis is unavoidable, give during the final 30 minutes and consider dose increase 2
Important Caveats
- This recommendation assumes a bacteremia/endocarditis indication (6 mg/kg base dose per FDA label and IDSA guidelines 6, 1)
- For complicated skin/soft tissue infections only, the base dose would be 4 mg/kg (340 mg), with 510 mg before the 72-hour gap
- The FDA label does not provide specific guidance for thrice-weekly dosing, but the pharmacokinetic literature strongly supports this approach over strict every-48-hour dosing that creates schedule conflicts 2, 3, 4, 7